The global functional food market is experiencing robust growth, driven by consumer demand for proactive health management and natural ingredients. Regulatory bodies are increasingly supporting science-backed health claims, creating opportunities for products like this fermented dairy. Competition is intensifying for innovative, natural solutions that address chronic conditions like Type 2 diabetes, pushing companies to seek differentiated offerings.
Delivers high DPP-4 inhibitory activity through a unique mushroom fermentation process, enabling a natural, food-derived product appeal.
Contributes to preventive healthcare by supporting Type 2 diabetes prevention and management through diet, with potential for pharmaceutical applications.
Establishes robust patentability by successfully addressing examiner objections against 7 prior art documents, ensuring a stable and difficult-to-invalidate intellectual property foundation.
This patent protects a mushroom-fermented dairy product with high DPP-4 inhibitory activity and its production method. Its robust patentability was established through successful navigation of examiner objections against prior art, indicating a strong defense against invalidation and broad, clearly defined claims.
This patent primarily covers mushroom-fermented dairy for DPP-4 inhibition. White space exists in exploring alternative fermentation substrates, non-dairy applications, or isolating specific bioactive compounds for broader pharmaceutical or cosmetic uses.
The functional food market is growing at ~10% annually. Introducing high-value fermented dairy products based on this technology could enhance existing product annual sales of ~$65M (AI est.) by 5%, adding ~$3.5M (AI est.) in value. Additionally, new market expansion could contribute ~$0.7M (AI est.) in annual sales, potentially generating a total economic impact of ~$1.0M (AI est.) per year.
X: Health Functionality
Y: Natural Origin & Safety